Applying an equity lens to pharmacogenetic research and translation to under‐represented populations
Abstract Since the publication of the Human Genome Project, genetic information has been used as an accepted, evidence‐based biomarker to optimize patient care through the delivery of precision health. Pharmacogenetics (PGx) uses information about genes that encode proteins involved in pharmacokinet...
Guardado en:
Autores principales: | Tiana Luczak, David Stenehjem, Jacob Brown |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01706e9b3401492586aa6d711cc72e8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of population‐level pharmacogenetic actionability in Alabama
por: Brittney H. Davis, et al.
Publicado: (2021) -
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Debora Curci, et al.
Publicado: (2021) -
Ad Hominem Criticisms: An Old Trick to Discredit Inconvenient Research. A Response to Oakley et al. And the International Chiropractors Association Rapid Response Research Review Subcommittee
por: Pierre Côté, et al.
Publicado: (2021) -
Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013) -
Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Zachary L. Taylor, et al.
Publicado: (2021)